EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Effects of Selected Anionic β -Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats

Keiko Uehata, Takayuki Anno, Kayoko Hayashida, Keiichi Motoyama, Taishi Higashi, Fumitoshi Hirayama, Naomi Ono, James D. Pipkin, Kaneto Uekama, Hidetoshi Arima

Journal of Drug Delivery · 2011

DOI: 10.1155/2011/195146 ↗
AbstractBibliografische Angaben

Abstract

Insulin glargine is a synthetic long-acting insulin product used for patients with diabetes mellitus. In this study, to obtain the further desirable blood-glucose lowering profile of insulin glargine, we investigated the effects of β -cyclodextrin sulfate (Sul- β -CyD) and sulfobutylether β -cyclodextrin (SBE7- β -CyD) on physicochemical properties of insulin glargine and pharmacokinetics/pharmacodynamics of insulin glargine after subcutaneous injection to rats. Sul- β -CyD and SBE7- β -CyD increased solubility of insulin glargine. SBE7- β -CyD suppressed the formation of oligomer and enhanced the dissolution rate of insulin glargine from its precipitate, compared to that of Sul- β -CyD. Additionally, we revealed that after subcutaneous administration of an insulin glargine solution, SBE7- β -CyD, but not Sul- β -CyD, increased bioavailability and sustained the blood-glucose lowering effect, possibly due to the inhibitory effects of SBE7- β -CyD on the enzymatic degradation at the injection site. These results suggest that SBE7- β -CyD could be a useful excipient for sustained release of insulin glargine.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →